References
Key articles
Nguyen GC, Smalley WE, Vege SS, et al. American Gastroenterological Association Institute guideline on the medical management of microscopic colitis. Gastroenterology. 2016 Jan;150(1):242-6.Full text Abstract
Arasaradnam RP, Brown S, Forbes A, et al. Guidelines for the investigation of chronic diarrhoea in adults: British Society of Gastroenterology, 3rd edition. Gut. 2018 Aug;67(8):1380-99.Full text Abstract
Miehlke S, Guagnozzi D, Zabana Y, et al. European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendations. United European Gastroenterol J. 2021 Feb 22;9(1):13-37.Full text Abstract
Reference articles
1. Miehlke S, Verhaegh B, Tontini GE, et al. Microscopic colitis: pathophysiology and clinical management. Lancet Gastroenterol Hepatol. 2019 Apr;4(4):305-14. Abstract
2. Münch A, Sanders DS, Molloy-Bland M, et al. Undiagnosed microscopic colitis: a hidden cause of chronic diarrhoea and a frequently missed treatment opportunity. Frontline Gastroenterol. 2019 Jul 5;11(3):228-34.Full text Abstract
3. Nguyen GC, Smalley WE, Vege SS, et al. American Gastroenterological Association Institute guideline on the medical management of microscopic colitis. Gastroenterology. 2016 Jan;150(1):242-6.Full text Abstract
4. Józefczuk J, Wozniewicz BM. Clear cell colitis: a form of microscopic colitis in children. World J Gastroenterol. 2008 Jan 14;14(2):231-5.Full text Abstract
5. Arasaradnam RP, Brown S, Forbes A, et al. Guidelines for the investigation of chronic diarrhoea in adults: British Society of Gastroenterology, 3rd edition. Gut. 2018 Aug;67(8):1380-99.Full text Abstract
6. Miehlke S, Guagnozzi D, Zabana Y, et al. European guidelines on microscopic colitis: United European Gastroenterology and European Microscopic Colitis Group statements and recommendations. United European Gastroenterol J. 2021 Feb 22;9(1):13-37.Full text Abstract
7. Tome J, Kamboj AK, Pardi DS. Microscopic colitis: a concise review for clinicians. Mayo Clin Proc. 2021 May;96(5):1302-8.Full text Abstract
8. Münch A, Aust D, Bohr J, et al. Microscopic colitis: current status, present and future challenges: statements of the European Microscopic Colitis Group. J Crohns Colitis. 2012 Oct;6(9):932-45.Full text Abstract
9. Burke KE, D'Amato M, Ng SC, et al. Microscopic colitis. Nat Rev Dis Primers. 2021 Jun 10;7(1):39. Abstract
10. Tong J, Zheng Q, Zhang C, et al. Incidence, prevalence, and temporal trends of microscopic colitis: a systematic review and meta-analysis. Am J Gastroenterol. 2015 Feb;110(2):265-76. Abstract
11. Olesen M, Eriksson S, Bohr J, et al. Microscopic colitis: a common diarrhoeal disease. An epidemiological study in Orebro, Sweden, 1993-1998. Gut. 2004 Mar;53(3):346-50.Full text Abstract
12. Münch A, Langner C. Microscopic colitis: clinical and pathologic perspectives. Clin Gastroenterol Hepatol. 2015 Feb;13(2):228-36.Full text Abstract
13. Lewis N, Archer T, Kaye. PPWE-061 Epidemiology of microscopic colitis in Nottingham: a contemporary cohort study. Gut. 2017 Jun 17;66:A156.Full text
14. Pardi DS. Diagnosis and management of microscopic colitis. Am J Gastroenterol. 2017 Jan;112(1):78-85. Abstract
15. Gentile NM, Khanna S, Loftus EV Jr, et al. The epidemiology of microscopic colitis in Olmsted County from 2002 to 2010: a population-based study. Clin Gastroenterol Hepatol. 2014 May;12(5):838-42.Full text Abstract
16. Bohr J, Tysk C, Eriksson S, et al. Collagenous colitis: a retrospective study of clinical presentation and treatment in 163 patients. Gut. 1996 Dec;39(6):846-51.Full text Abstract
17. Bonderup OK, Wigh T, Nielsen GL, et al. The epidemiology of microscopic colitis: a 10-year pathology-based nationwide Danish cohort study. Scand J Gastroenterol. 2015 Apr;50(4):393-8. Abstract
18. Verhaegh BP, Jonkers DM, Driessen A, et al. Incidence of microscopic colitis in the Netherlands. A nationwide population-based study from 2000 to 2012. Dig Liver Dis. 2015 Jan;47(1):30-6. Abstract
19. Bergman D, Clements MS, Khalili H, et al. A nationwide cohort study of the incidence of microscopic colitis in Sweden. Aliment Pharmacol Ther. 2019 Jun;49(11):1395-400. Abstract
20. Fumery M, Kohut M, Gower-Rousseau C, et al. Incidence, clinical presentation, and associated factors of microscopic colitis in northern France: a population-based study. Dig Dis Sci. 2017 Jun;62(6):1571-9. Abstract
21. Park T, Cave D, Marshall C. Microscopic colitis: a review of etiology, treatment and refractory disease. World J Gastroenterol. 2015 Aug 7;21(29):8804-10.Full text Abstract
22. Stewart M, Andrews CN, Urbanski S, et al. The association of coeliac disease and microscopic colitis: a large population-based study. Aliment Pharmacol Ther. 2011 Jun;33(12):1340-9.Full text Abstract
23. Green PH, Yang J, Cheng J, et al. An association between microscopic colitis and celiac disease. Clin Gastroenterol Hepatol. 2009 Nov;7(11):1210-6.Full text Abstract
24. Masclee GM, Coloma PM, Kuipers EJ, et al. Increased risk of microscopic colitis with use of proton pump inhibitors and non-steroidal anti-inflammatory drugs. Am J Gastroenterol. 2015 May;110(5):749-59. Abstract
25. Bonderup OK, Nielsen GL, Dall M, et al. Significant association between the use of different proton pump inhibitors and microscopic colitis: a nationwide Danish case-control study. Aliment Pharmacol Ther. 2018 Sep;48(6):618-25. Abstract
26. Mori S, Kadochi Y, Luo Y, et al. Proton pump inhibitor induced collagen expression in colonocytes is associated with collagenous colitis. World J Gastroenterol. 2017 Mar 7;23(9):1586-93.Full text Abstract
27. Verhaegh BP, de Vries F, Masclee AA, et al. High risk of drug-induced microscopic colitis with concomitant use of NSAIDs and proton pump inhibitors. Aliment Pharmacol Ther. 2016 May;43(9):1004-13.Full text Abstract
28. Tarar ZI, Farooq U, Gandhi M, et al. Are drugs associated with microscopic colitis? A systematic review and meta-analysis. Diseases. 2022 Dec 29;11(1):6.Full text Abstract
29. Gleeson MH, Davis AJ. Non-steroidal anti-inflammatory drugs, aspirin and newly diagnosed colitis: a case-control study. Aliment Pharmacol Ther. 2003 Mar 15;17(6):817-25.Full text Abstract
30. Mihaly E, Patai Á, Tulassay Z. Controversials of microscopic colitis. Front Med (Lausanne). 2021 Oct 12;8:717438.Full text Abstract
31. Bhatt AP, Gunasekara DB, Speer J, et al. Nonsteroidal anti-inflammatory drug-induced leaky gut modeled using polarized monolayers of primary human intestinal epithelial cells. ACS Infect Dis. 2018 Jan 12;4(1):46-52.Full text Abstract
32. Berg DJ, Zhang J, Weinstock JV, et al. Rapid development of colitis in NSAID-treated IL-10-deficient mice. Gastroenterology. 2002 Nov;123(5):1527-42.Full text Abstract
33. Zylberberg H, Kamboj AK, Cuir N, et al. Medication use and microscopic colitis: a multicenter retrospective cohort study. Gastroenterology. 2020;158:S-170.
34. Millien V, Rosen D, Hou J, et al. Proinflammatory sulfur-reducing bacteria are more abundant in colonic biopsies of patients with microscopic colitis compared to healthy controls. Dig Dis Sci. 2019 Feb;64(2):432-8. Abstract
35. Cappell MS. Colonic toxicity of administered drugs and chemicals. Am J Gastroenterol. 2004 Jun;99(6):1175-90. Abstract
36. Torres J, Palmela C, Gomes de Sena P, et al. Farnesoid X receptor expression in microscopic colitis: a potential role in disease etiopathogenesis. GE Port J Gastroenterol. 2018 Jan;25(1):30-7.Full text Abstract
37. Vigren L, Tysk C, Ström M, et al. Celiac disease and other autoimmune diseases in patients with collagenous colitis. Scand J Gastroenterol. 2013 Aug;48(8):944-50. Abstract
38. Wickbom A, Nyhlin N, Montgomery SM, et al. Family history, comorbidity, smoking and other risk factors in microscopic colitis: a case-control study. Eur J Gastroenterol Hepatol. 2017 May;29(5):587-94.Full text Abstract
39. Ung KA, Gillberg R, Kilander A, et al. Role of bile acids and bile acid binding agents in patients with collagenous colitis. Gut. 2000 Feb;46(2):170-5.Full text Abstract
40. Fernandez-Bañares F, Esteve M, Salas A, et al. Bile acid malabsorption in microscopic colitis and in previously unexplained functional chronic diarrhea. Dig Dis Sci. 2001 Oct;46(10):2231-8. Abstract
41. Fischer H, Holst E, Karlsson F, et al. Altered microbiota in microscopic colitis. Gut. 2015 Jul;64(7):1185-6.Full text Abstract
42. Günther U, Bateman AC, Beattie RM, et al. Connective tissue growth factor expression is increased in collagenous colitis and coeliac disease. Histopathology. 2010 Sep;57(3):427-35. Abstract
43. Macaigne G, Lahmek P, Locher C, et al. Microscopic colitis or functional bowel disease with diarrhea: a French prospective multicenter study. Am J Gastroenterol. 2014 Sep;109(9):1461-70. Abstract
44. Yen EF, Pokhrel B, Du H, et al. Current and past cigarette smoking significantly increase risk for microscopic colitis. Inflamm Bowel Dis. 2012 Oct;18(10):1835-41. Abstract
45. Vigren L, Sjöberg K, Benoni C, et al. Is smoking a risk factor for collagenous colitis?. Scand J Gastroenterol. 2011 Nov;46(11):1334-9. Abstract
46. Münch A, Tysk C, Bohr J, et al. Smoking status influences clinical outcome in collagenous colitis. J Crohns Colitis. 2016 Apr;10(4):449-54.Full text Abstract
47. Jaruvongvanich V, Poonsombudlert K, Ungprasert P. Smoking and risk of microscopic colitis: a systematic review and meta-analysis. Inflamm Bowel Dis. 2019 Mar 14;25(4):672-8.Full text Abstract
48. Bohr J, Wickbom A, Hegedus A, et al. Diagnosis and management of microscopic colitis: current perspectives. Clin Exp Gastroenterol. 2014 Aug 21;7:273-84.Full text Abstract
49. Batista L, Ruiz L, Ferrer C, et al. Usefulness of fecal calprotectin as a biomarker of microscopic colitis in a cohort of patients with chronic watery diarrhoea of functional characteristics. Dig Liver Dis. 2019 Dec;51(12):1646-51. Abstract
50. von Arnim U, Wex T, Ganzert C, et al. Fecal calprotectin: a marker for clinical differentiation of microscopic colitis and irritable bowel syndrome. Clin Exp Gastroenterol. 2016 Apr 21;9:97-103.Full text Abstract
51. van der Windt DA, Jellema P, Mulder CJ, et al. Diagnostic testing for celiac disease among patients with abdominal symptoms: a systematic review. JAMA. 2010 May 5;303(17):1738-46.Full text Abstract
52. Pardi DS, Ramnath VR, Loftus EV Jr, et al. Lymphocytic colitis: clinical features, treatment, and outcomes. Am J Gastroenterol. 2002 Nov;97(11):2829-33. Abstract
53. Lichtenstein GR, Loftus EV, Isaacs KL, et al. ACG clinical guideline: management of Crohn's disease in adults. Am J Gastroenterol. 2018 Apr;113(4):481-517.Full text Abstract
54. American Society for Gastrointestinal Endoscopy Standards of Practice Committee, Shergill AK, Lightdale JR, et al. The role of endoscopy in inflammatory bowel disease. Gastrointest Endosc. 2015 May;81(5):1101-21.e1-13.Full text Abstract
55. Leffler DA, Dennis M, Hyett B, et al. Etiologies and predictors of diagnosis in nonresponsive celiac disease. Clin Gastroenterol Hepatol. 2007 Apr;5(4):445-50.Full text Abstract
56. Leffler DA, Kelly CP. Update on the evaluation and diagnosis of celiac disease. Curr Opin Allergy Clin Immunol. 2006 Jun;6(3):191-6. Abstract
57. Lacy BE, Pimentel M, Brenner DM, et al. ACG clinical guideline: management of irritable bowel syndrome. Am J Gastroenterol. 2021 Jan 1;116(1):17-44.Full text Abstract
58. Hjortswang H, Tysk C, Bohr J, et al. Defining clinical criteria for clinical remission and disease activity in collagenous colitis. Inflamm Bowel Dis. 2009 Dec;15(12):1875-81. Abstract
60. Fine KD, Lee EL. Efficacy of open-label bismuth subsalicylate for the treatment of microscopic colitis. Gastroenterology. 1998 Jan;114(1):29-36. Abstract
61. Fine K, Ogunji F, Lee E, et al. Randomized, double-blind, placebo-controlled trial of bismuth subsalicylate for microscopic colitis (abstract). Gastroenterology. 1999;116:880.
62. Masannat Y, Nazer E. Pepto bismuth associated neurotoxicity: a rare side effect of a commonly used medication. W V Med J. 2013 May-Jun;109(3):32-4. Abstract
63. Gentile NM, Abdalla AA, Khanna S, et al. Outcomes of patients with microscopic colitis treated with corticosteroids: a population-based study. Am J Gastroenterol. 2013 Feb;108(2):256-9.Full text Abstract
64. Sloth H, Bisgaard C, Grove A. Collagenous colitis: a prospective trial of prednisolone in six patients. J Intern Med. 1991 May;229(5):443-6. Abstract
65. Kafil TS, Nguyen TM, Patton PH, et al. Interventions for treating collagenous colitis. Cochrane Database Syst Rev. 2017 Nov 11;11(11):CD003575.Full text Abstract
66. Chande N, Al Yatama N, Bhanji T, et al. Interventions for treating lymphocytic colitis. Cochrane Database Syst Rev. 2017 Jul 13;7(7):CD006096.Full text Abstract
67. Miehlke S, Madisch A, Kupcinskas L, et al. Budesonide is more effective than mesalamine or placebo in short-term treatment of collagenous colitis. Gastroenterology. 2014 May;146(5):1222-30.e1-2.Full text Abstract
68. Cotter TG, Kamboj AK, Hicks SB, et al. Immune modulator therapy for microscopic colitis in a case series of 73 patients. Aliment Pharmacol Ther. 2017 Jul;46(2):169-74.Full text Abstract
69. Esteve M, Mahadevan U, Sainz E, et al. Efficacy of anti-TNF therapies in refractory severe microscopic colitis. J Crohns Colitis. 2011 Dec;5(6):612-8.Full text Abstract
70. Münch A, Ignatova S, Ström M. Adalimumab in budesonide and methotrexate refractory collagenous colitis. Scand J Gastroenterol. 2012 Jan;47(1):59-63. Abstract
71. Pola S, Fahmy M, Evans E, Tipps A, Sandborn WJ. Successful use of infliximab in the treatment of corticosteroid dependent collagenous colitis. Am J Gastroenterol. 2013 May;108(5):857-8. Abstract
72. Münch A, Fernandez-Banares F, Munck LK. Azathioprine and mercaptopurine in the management of patients with chronic, active microscopic colitis. Aliment Pharmacol Ther. 2013 Apr;37(8):795-8.Full text Abstract
73. Taneja V, El-Dallal M, Anand RS, et al. Efficacy and safety of biologic therapy in microscopic colitis: systematic review and meta-analysis. Eur J Gastroenterol Hepatol. 2022 Oct 1;34(10):1000-6. Abstract
74. Jennings JJ, Charabaty A. Vedolizumab-induced remission in 3 patients with refractory microscopic colitis: a tertiary care center case series. Inflamm Bowel Dis. 2019 Jul 17;25(8):e97.Full text Abstract
75. Rivière P, Münch A, Michetti P, et al. Vedolizumab in refractory microscopic colitis: an international case series. J Crohns Colitis. 2019 Mar 26;13(3):337-40.Full text Abstract
76. Cushing KC, Mino-Kenudson M, Garber J, et al. Vedolizumab as a novel treatment for refractory collagenous colitis: a case report. Am J Gastroenterol. 2018 Apr;113(4):632-3. Abstract
77. Cottreau J, Kelly R, Topp T, et al. Spontaneous colonic perforation: a rare complication of collagenous colitis. Clin J Gastroenterol. 2016 Jun;9(3):140-4. Abstract
78. Münch A, Bohr J, Miehlke S, et al. Low-dose budesonide for maintenance of clinical remission in collagenous colitis: a randomised, placebo-controlled, 12-month trial. Gut. 2016 Jan;65(1):47-56.Full text Abstract
79. Abughazaleh S, Glassner K, Wilhite A, et al. A stellar case of stelara in the treatment of lymphocytic colitis. American Journal of Gastroenterology. 2019;114:S1154.Full text
80. Lenfant M, De Hertogh G, Verstockt B. Tofacitinib for celiac disease and microscopic colitis: killing two birds with one stone. Acta Gastroenterol Belg. 2023 Apr-Jun;86(2):374-6.Full text Abstract
81. American Gastroenterological Association. Medical management of microscopic colitis. Nov 2015 [internet publication].Full text
Use of this content is subject to our disclaimer